RxDoctor Payments DataLook up a doctor →

Jo Anna Warren

Nurse Practitioner · Jackson, MSNPI 1730196353

Payments from drug & device makers

$72,841in general payments, 2019–2025

Across 994 payments — averaging $73.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$48K
  • Abbott$11K
  • Lilly USA, LLC$2K
  • Amgen$1K
  • AbbVie$1K
  • Medtronic$916
  • plus $8K from 40 others

What the payments were for

  • Consulting fees$3,8005%
  • Speaking & faculty fees$47,10765%
  • Travel & lodging$4,7897%
  • Food & beverage$17,08923%
  • Education$570%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$72,841 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$196,838
Medicare patients
433
Services billed
11,083

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide474$617,649
Tresiba Flextouch U-100Insulin Degludec663$408,276
MounjaroTirzepatide312$387,148
JardianceEmpagliflozin292$279,294
Tresiba Flextouch U-200Insulin Degludec183$157,048
Synjardy XrEmpagliflozin/Metformin Hcl128$107,889
Fiasp FlextouchInsulin Aspart (Niacinamide)148$107,774
FarxigaDapagliflozin Propanediol133$105,285
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog155$83,738
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/769$69,650
TrulicityDulaglutide60$66,508
Novolog FlexpenInsulin Aspart263$62,353
Xigduo XrDapaglifloz Propaned/Metformin90$56,842
Soliqua 100-33Insulin Glargine/Lixisenatide51$49,967
Trijardy XrEmpaglifloz/Linaglip/Metformin61$49,349

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog, Rybelsus, Fiasp$48,372$734,066672 claims
Boehringer IngelheimJardiance, Synjardy Xr, Trijardy Xr, Tradjenta, Glyxambi$704$554,732634 claims
Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Humalog, Insulin Lispro$2,183$485,125510 claims
AstraZenecaFarxiga$481$105,285133 claims
MerckJanumet Xr, Janumet, Januvia$64$66,65272 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$584$49,96751 claims
AbbVieSynthroid$1,103$7,30572 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →